ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts Post ContentadctRead More You might also be interested in reading Malone Lam pleads guilty in $245M crypto theft conspiracy. August 12, 2025 In Mainstream ← Previous post Next post →